Home » Topics » BioWorld Science

BioWorld Science
RSS

CD300a blockade ameliorates neuronal deficit after ischemic stroke

Oct. 29, 2021

THAP1 gene variation associated with neurodevelopmental disorders and impaired myelination

Oct. 29, 2021

Targeting IKK-beta in cardiac fibroblasts may protect against heart failure

Oct. 28, 2021

[64Cu]CuHTE1PA-9E7.4 use as a theranostic agent for multiple myeloma

Oct. 28, 2021

Chemoattractant attachment boosts antibiotic efficacy

Oct. 28, 2021

99mTc-Labeled rituximab allows imaging of CD-20-expressing melanoma

Oct. 28, 2021

Novel anti-inflammatory agent significantly improves LPS-induced sepsis in vivo

Oct. 28, 2021

JMV-7488, a new 68Ga-radiolabeled peptide analogue for cancer imaging

Oct. 28, 2021

New ENPP1 inhibitors discovered at Betta Pharmaceuticals

Oct. 28, 2021

ADAMTS5 inhibitors patented by Shenzhen Salubris Pharmaceuticals

Oct. 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...